TreeWAS – Variant ID: rs2844510

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E03.9 Hypothyroidism, unspecified	0.000	0.000	1.000
M45.X9 Ankylosing spondylitis (Site unspecified)	1.000	0.000	0.000
E00-E07 Disorders of thyroid gland	0.000	0.000	1.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.000	1.000
M45 Ankylosing spondylitis	1.000	0.000	0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	1.000	0.000	0.000
E03 Other hypothyroidism	0.000	0.000	1.000
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.001	0.999
E70-E90 Metabolic disorders	0.000	0.002	0.998
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.000	0.002	0.998
Chapter II Neoplasms	0.000	0.002	0.998
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.000	0.003	0.997
C43-C44 Melanoma and other malignant neoplasms of skin	0.000	0.003	0.997
C44 Other malignant neoplasms of skin	0.000	0.003	0.997
E89.0 Postprocedural hypothyroidism	0.000	0.004	0.996
C44.3 Skin of other and unspecified parts of face	0.000	0.004	0.996
E05.9 Thyrotoxicosis, unspecified	0.000	0.005	0.995
C79 Secondary malignant neoplasm of other sites	0.000	0.005	0.995
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.000	0.007	0.993
G35 Multiple sclerosis	0.000	0.009	0.991
# Top node	0.000	0.011	0.989
C44.4 Skin of scalp and neck	0.000	0.014	0.986
C79.8 Secondary malignant neoplasm of other specified sites	0.000	0.014	0.986
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.000	0.015	0.985
G35-G37 Demyelinating diseases of the central nervous system	0.000	0.015	0.985
C34 Malignant neoplasm of bronchus and lung	0.000	0.016	0.984
Chapter VI Diseases of the nervous system	0.000	0.018	0.982
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.000	0.020	0.980
C34.9 Bronchus or lung, unspecified	0.000	0.028	0.972
E87 Other disorders of fluid, electrolyte and acid-base balance	0.000	0.031	0.969
Chapter XII Diseases of the skin and subcutaneous tissue	0.000	0.034	0.966
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.040	0.960
L40-L45 Papulosquamous disorders	0.000	0.044	0.956
L40.9 Psoriasis, unspecified	0.000	0.044	0.956
L40 Psoriasis	0.000	0.046	0.954
E87.6 Hypokalaemia	0.000	0.048	0.952
M45.X2 Ankylosing spondylitis (Cervical region)	0.948	0.052	0.000
E10-E14 Diabetes mellitus	0.000	0.055	0.945
E10 Insulin-dependent diabetes mellitus	0.000	0.062	0.938
C78.0 Secondary malignant neoplasm of lung	0.000	0.066	0.934
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.000	0.077	0.923
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.000	0.078	0.922
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.079	0.921
E06 Thyroiditis	0.000	0.088	0.912
G80-G83 Cerebral palsy and other paralytic syndromes	0.000	0.088	0.912
E20-E35 Disorders of other endocrine glands	0.000	0.094	0.906
Chapter V Mental and behavioural disorders	0.000	0.095	0.905
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.000	0.097	0.903
D69 Purpura and other haemorrhagic conditions	0.000	0.100	0.900
F00-F09 Organic, including symptomatic, mental disorders	0.000	0.101	0.899
C34.3 Lower lobe, bronchus or lung	0.000	0.106	0.894
E10.9 Without complications	0.000	0.112	0.888
G70-G73 Diseases of myoneural junction and muscle	0.000	0.112	0.888
E10.3 With ophthalmic complications	0.000	0.115	0.885
E27 Other disorders of adrenal gland	0.000	0.120	0.880
L20-L30 Dermatitis and eczema	0.000	0.126	0.874
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.000	0.127	0.873
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.000	0.136	0.864
F03 Unspecified dementia	0.000	0.143	0.857
G30-G32 Other degenerative diseases of the nervous system	0.000	0.143	0.857
E06.3 Autoimmune thyroiditis	0.000	0.149	0.851
D60-D64 Aplastic and other anaemias	0.000	0.158	0.842
E40-E46 Malnutrition	0.000	0.162	0.838
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.163	0.837
C34.2 Middle lobe, bronchus or lung	0.000	0.165	0.835
C79.6 Secondary malignant neoplasm of ovary	0.000	0.169	0.831
G82 Paraplegia and tetraplegia	0.000	0.170	0.830
C44.0 Skin of lip	0.000	0.171	0.829
D69.3 Idiopathic thrombocytopenic purpura	0.000	0.172	0.828
E87.1 Hypo-osmolality and hyponatraemia	0.000	0.174	0.826
E73 Lactose intolerance	0.000	0.177	0.823
C44.2 Skin of ear and external auricular canal	0.000	0.178	0.822
E27.1 Primary adrenocortical insufficiency	0.000	0.179	0.821
E10.1 With ketoacidosis	0.000	0.180	0.820
D69.5 Secondary thrombocytopenia	0.000	0.181	0.819
L29 Pruritus	0.000	0.188	0.812
D64 Other anaemias	0.000	0.190	0.810
C34.1 Upper lobe, bronchus or lung	0.000	0.190	0.810
G81 Hemiplegia	0.000	0.196	0.804
C15-C26 Malignant neoplasms of digestive organs	0.000	0.196	0.804
L57 Skin changes due to chronic exposure to nonionising radiation	0.000	0.201	0.799
C18 Malignant neoplasm of colon	0.000	0.201	0.799
E88 Other metabolic disorders	0.000	0.204	0.796
G70 Myasthenia gravis and other myoneural disorders	0.000	0.204	0.796
D55-D59 Haemolytic anaemias	0.000	0.204	0.796
F05 Delirium, not induced by alcohol and other psychoactive substances	0.000	0.214	0.786
M45.X6 Ankylosing spondylitis (Lumbar region)	0.783	0.217	0.000
D64.9 Anaemia, unspecified	0.000	0.217	0.783
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.222	0.778
D80-D89 Certain disorders involving the immune mechanism	0.000	0.225	0.775
C18.2 Ascending colon	0.000	0.227	0.773
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.000	0.228	0.772
E74 Other disorders of carbohydrate metabolism	0.000	0.233	0.767
F01 Vascular dementia	0.000	0.235	0.765
F00 Dementia in Alzheimer's disease	0.000	0.236	0.764
L57.0 Actinic keratosis	0.000	0.237	0.763
L29.0 Pruritus ani	0.000	0.239	0.761
E10.4 With neurological complications	0.000	0.243	0.757
C64-C68 Malignant neoplasms of urinary tract	0.000	0.243	0.757
D69.6 Thrombocytopenia, unspecified	0.000	0.251	0.749
H20.9 Iridocyclitis, unspecified	0.748	0.252	0.000
E20 Hypoparathyroidism	0.000	0.256	0.744
G82.2 Paraplegia, unspecified	0.000	0.258	0.742
F05.9 Delirium, unspecified	0.000	0.261	0.739
E89.2 Postprocedural hypoparathyroidism	0.000	0.261	0.739
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.000	0.265	0.735
D69.0 Allergic purpura	0.000	0.266	0.734
G70.0 Myasthenia gravis	0.000	0.270	0.730
E10.0 With coma	0.000	0.273	0.727
E03.8 Other specified hypothyroidism	0.000	0.275	0.725
C19 Malignant neoplasm of rectosigmoid junction	0.000	0.276	0.724
E46 Unspecified protein-energy malnutrition	0.000	0.277	0.723
G81.9 Hemiplegia, unspecified	0.000	0.277	0.723
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.000	0.278	0.722
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.000	0.278	0.721
E86 Volume depletion	0.000	0.279	0.721
L10-L14 Bullous disorders	0.000	0.279	0.721
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.000	0.281	0.719
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.283	0.717
E00 Congenital iodine-deficiency syndrome	0.000	0.283	0.717
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.283	0.717
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.717	0.283	0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.717	0.283	0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.717	0.283	0.000
M45.X4 Ankylosing spondylitis (Thoracic region)	0.717	0.283	0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.717	0.283	0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.717	0.283	0.000
E03.5 Myxoedema coma	0.000	0.283	0.717
E03.4 Atrophy of thyroid (acquired)	0.000	0.283	0.717
E03.3 Postinfectious hypothyroidism	0.000	0.283	0.717
E03.1 Congenital hypothyroidism without goitre	0.000	0.283	0.717
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.283	0.717
L21 Seborrhoeic dermatitis	0.000	0.283	0.717
E05.5 Thyroid crisis or storm	0.000	0.284	0.716
E05.4 Thyrotoxicosis factitia	0.000	0.284	0.716
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.284	0.716
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.284	0.716
E84 Cystic fibrosis	0.000	0.284	0.716
E79 Disorders of purine and pyrimidine metabolism	0.000	0.284	0.716
E77 Disorders of glycoprotein metabolism	0.000	0.284	0.716
E76 Disorders of glycosaminoglycan metabolism	0.000	0.284	0.716
E72 Other disorders of amino-acid metabolism	0.000	0.284	0.716
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.000	0.284	0.716
E70 Disorders of aromatic amino-acid metabolism	0.000	0.284	0.716
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.000	0.284	0.716
E07 Other disorders of thyroid	0.000	0.284	0.716
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.000	0.285	0.715
E89.8 Other postprocedural endocrine and metabolic disorders	0.000	0.285	0.715
E89.5 Postprocedural testicular hypofunction	0.000	0.285	0.715
E89.4 Postprocedural ovarian failure	0.000	0.285	0.715
E89.1 Postprocedural hypoinsulinaemia	0.000	0.285	0.715
C44.8 Overlapping lesion of skin	0.000	0.285	0.715
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.000	0.287	0.713
D68 Other coagulation defects	0.000	0.288	0.712
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.000	0.288	0.712
D86 Sarcoidosis	0.000	0.289	0.711
C76 Malignant neoplasm of other and ill-defined sites	0.000	0.290	0.710
Chapter XVI Certain conditions originating in the perinatal period	0.000	0.291	0.709
E87.7 Fluid overload	0.000	0.291	0.709
L40.0 Psoriasis vulgaris	0.000	0.292	0.708
F02 Dementia in other diseases classified elsewhere	0.000	0.293	0.707
G71 Primary disorders of muscles	0.000	0.293	0.707
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.000	0.293	0.706
C31 Malignant neoplasm of accessory sinuses	0.000	0.293	0.706
C30 Malignant neoplasm of nasal cavity and middle ear	0.000	0.293	0.706
G36 Other acute disseminated demyelination	0.000	0.293	0.706
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.000	0.293	0.706
C34.8 Overlapping lesion of bronchus and lung	0.000	0.294	0.705
E65-E68 Obesity and other hyperalimentation	0.000	0.296	0.704
E50-E64 Other nutritional deficiencies	0.000	0.297	0.703
E22 Hyperfunction of pituitary gland	0.000	0.299	0.701
C34.0 Main bronchus	0.000	0.300	0.700
C78.1 Secondary malignant neoplasm of mediastinum	0.000	0.300	0.700
G82.1 Spastic paraplegia	0.000	0.302	0.698
G30 Alzheimer's disease	0.000	0.302	0.698
E73.9 Lactose intolerance, unspecified	0.000	0.302	0.698
E89.3 Postprocedural hypopituitarism	0.000	0.304	0.695
C18.4 Transverse colon	0.000	0.305	0.695
E87.4 Mixed disorder of acid-base balance	0.000	0.305	0.694
Chapter VIII Diseases of the ear and mastoid process	0.000	0.307	0.693
L29.9 Pruritus, unspecified	0.000	0.309	0.691
C18.5 Splenic flexure	0.000	0.311	0.689
L40.8 Other psoriasis	0.000	0.313	0.687
F00.9 Dementia in Alzheimer's disease, unspecified	0.000	0.314	0.686
L44 Other papulosquamous disorders	0.000	0.314	0.686
L41 Parapsoriasis	0.000	0.314	0.686
L45 Papulosquamous disorders in diseases classified elsewhere	0.000	0.314	0.686
L40.4 Guttate psoriasis	0.000	0.316	0.684
L40.3 Pustulosis palmaris et plantaris	0.000	0.316	0.684
L40.2 Acrodermatitis continua	0.000	0.316	0.684
L40.1 Generalised pustular psoriasis	0.000	0.316	0.684
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.319	0.681
M45-M49 Spondylopathies	0.680	0.320	0.000
E12 Malnutrition-related diabetes mellitus	0.000	0.322	0.678
F20 Schizophrenia	0.000	0.324	0.676
D37-D48 Neoplasms of uncertain or unknown behaviour	0.000	0.325	0.675
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.325	0.675
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.000	0.326	0.674
E10.7 With multiple complications	0.000	0.327	0.673
F70-F79 Mental retardation	0.000	0.331	0.668
E27.9 Disorder of adrenal gland, unspecified	0.000	0.331	0.668
F01.9 Vascular dementia, unspecified	0.000	0.332	0.668
D59 Acquired haemolytic anaemia	0.000	0.333	0.667
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.000	0.335	0.665
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.000	0.335	0.665
D67 Hereditary factor IX deficiency	0.000	0.338	0.662
C79.7 Secondary malignant neoplasm of adrenal gland	0.000	0.340	0.660
C38 Malignant neoplasm of heart, mediastinum and pleura	0.000	0.340	0.660
F80-F89 Disorders of psychological development	0.000	0.342	0.658
C44.9 Malignant neoplasm of skin, unspecified	0.000	0.344	0.656
E27.8 Other specified disorders of adrenal gland	0.000	0.346	0.654
E06.5 Other chronic thyroiditis	0.000	0.346	0.654
E06.4 Drug-induced thyroiditis	0.000	0.346	0.654
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.000	0.346	0.654
E06.1 Subacute thyroiditis	0.000	0.346	0.654
E06.0 Acute thyroiditis	0.000	0.346	0.654
D69.4 Other primary thrombocytopenia	0.000	0.348	0.652
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.350	0.649
E32 Diseases of thymus	0.000	0.350	0.649
E31 Polyglandular dysfunction	0.000	0.350	0.649
E30 Disorders of puberty, not elsewhere classified	0.000	0.350	0.649
E25 Adrenogenital disorders	0.000	0.350	0.649
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.000	0.351	0.649
L29.8 Other pruritus	0.000	0.353	0.647
C18.3 Hepatic flexure	0.000	0.353	0.647
G80 Infantile cerebral palsy	0.000	0.354	0.646
D69.8 Other specified haemorrhagic conditions	0.000	0.354	0.645
D69.2 Other nonthrombocytopenic purpura	0.000	0.354	0.645
D69.1 Qualitative platelet defects	0.000	0.354	0.645
E10.5 With peripheral circulatory complications	0.000	0.355	0.645
F09 Unspecified organic or symptomatic mental disorder	0.000	0.355	0.645
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.000	0.355	0.645
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.000	0.356	0.644
E87.3 Alkalosis	0.000	0.356	0.644
C18.1 Appendix	0.000	0.356	0.644
C79.9 Secondary malignant neoplasm, unspecified site	0.000	0.358	0.642
C18.0 Caecum	0.000	0.358	0.642
C66 Malignant neoplasm of ureter	0.000	0.358	0.642
E06.9 Thyroiditis, unspecified	0.000	0.358	0.642
E26 Hyperaldosteronism	0.000	0.359	0.641
E34 Other endocrine disorders	0.000	0.360	0.640
D46 Myelodysplastic syndromes	0.000	0.362	0.638
E10.2 With renal complications	0.000	0.362	0.638
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere	0.000	0.363	0.636
F23 Acute and transient psychotic disorders	0.000	0.364	0.636
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.000	0.365	0.635
D00-D09 In situ neoplasms	0.000	0.365	0.635
C43 Malignant melanoma of skin	0.000	0.365	0.635
D86.9 Sarcoidosis, unspecified	0.000	0.366	0.634
L27 Dermatitis due to substances taken internally	0.000	0.367	0.633
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.000	0.368	0.632
E27.5 Adrenomedullary hyperfunction	0.000	0.369	0.631
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.369	0.631
E27.2 Addisonian crisis	0.000	0.369	0.631
E27.0 Other adrenocortical overactivity	0.000	0.369	0.631
G72 Other myopathies	0.000	0.369	0.631
C23 Malignant neoplasm of gallbladder	0.000	0.371	0.629
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.372	0.628
E20.9 Hypoparathyroidism, unspecified	0.000	0.372	0.628
G37 Other demyelinating diseases of central nervous system	0.000	0.373	0.627
L24 Irritant contact dermatitis	0.000	0.373	0.626
L26 Exfoliative dermatitis	0.000	0.373	0.626
L22 Diaper [napkin] dermatitis	0.000	0.373	0.626
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.000	0.374	0.626
L28 Lichen simplex chronicus and prurigo	0.000	0.374	0.626
E13 Other specified diabetes mellitus	0.000	0.375	0.625
C78.2 Secondary malignant neoplasm of pleura	0.000	0.376	0.624
D66 Hereditary factor VIII deficiency	0.000	0.376	0.624
E87.5 Hyperkalaemia	0.000	0.377	0.623
L20 Atopic dermatitis	0.000	0.380	0.620
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.000	0.381	0.619
L58 Radiodermatitis	0.000	0.381	0.619
L55 Sunburn	0.000	0.381	0.619
H80-H83 Diseases of inner ear	0.000	0.381	0.619
D64.8 Other specified anaemias	0.000	0.382	0.618
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.000	0.386	0.614
F25 Schizoaffective disorders	0.000	0.386	0.614
G31.2 Degeneration of nervous system due to alcohol	0.000	0.386	0.614
D06 Carcinoma in situ of cervix uteri	0.000	0.387	0.613
G30.9 Alzheimer's disease, unspecified	0.000	0.388	0.612
D46.9 Myelodysplastic syndrome, unspecified	0.000	0.388	0.612
E87.0 Hyperosmolality and hypernatraemia	0.000	0.390	0.610
C65 Malignant neoplasm of renal pelvis	0.000	0.391	0.609
G71.0 Muscular dystrophy	0.000	0.393	0.607
C26 Malignant neoplasm of other and ill-defined digestive organs	0.000	0.394	0.606
L21.9 Seborrhoeic dermatitis, unspecified	0.000	0.396	0.604
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.000	0.396	0.604
E10.6 With other specified complications	0.000	0.397	0.603
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.000	0.397	0.602
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.399	0.601
E45 Retarded development following protein-energy malnutrition	0.000	0.399	0.601
E43 Unspecified severe protein-energy malnutrition	0.000	0.399	0.601
E42 Marasmic kwashiorkor	0.000	0.399	0.601
E41 Nutritional marasmus	0.000	0.399	0.601
E40 Kwashiorkor	0.000	0.399	0.601
E74.3 Other disorders of intestinal carbohydrate absorption	0.000	0.399	0.600
C40-C41 Malignant neoplasms of bone and articular cartilage	0.000	0.399	0.600
Chapter IX Diseases of the circulatory system	0.000	0.400	0.600
E22.0 Acromegaly and pituitary gigantism	0.000	0.400	0.600
C33 Malignant neoplasm of trachea	0.000	0.401	0.599
D61 Other aplastic anaemias	0.000	0.401	0.599
D06.9 Cervix, unspecified	0.000	0.403	0.597
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.000	0.404	0.596
G82.3 Flaccid tetraplegia	0.000	0.405	0.595
G82.0 Flaccid paraplegia	0.000	0.405	0.595
L50-L54 Urticaria and erythema	0.000	0.405	0.595
I60-I69 Cerebrovascular diseases	0.000	0.405	0.595
G31.9 Degenerative disease of nervous system, unspecified	0.000	0.405	0.595
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.000	0.406	0.594
H80 Otosclerosis	0.000	0.409	0.591
E53 Deficiency of other B group vitamins	0.000	0.409	0.591
E73.8 Other lactose intolerance	0.000	0.410	0.590
E73.1 Secondary lactase deficiency	0.000	0.410	0.590
E73.0 Congenital lactase deficiency	0.000	0.410	0.590
D68.9 Coagulation defect, unspecified	0.000	0.410	0.590
C77.3 Axillary and upper limb lymph nodes	0.000	0.410	0.590
D58 Other hereditary haemolytic anaemias	0.000	0.410	0.590
G81.1 Spastic hemiplegia	0.000	0.410	0.589
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.000	0.411	0.589
Chapter I Certain infectious and parasitic diseases	0.000	0.411	0.589
L43 Lichen planus	0.000	0.412	0.588
L25 Unspecified contact dermatitis	0.000	0.412	0.588
F40-F48 Neurotic, stress-related and somatoform disorders	0.000	0.413	0.587
L56 Other acute skin changes due to ultraviolet radiation	0.000	0.414	0.586
E07.8 Other specified disorders of thyroid	0.000	0.415	0.585
C51-C58 Malignant neoplasms of female genital organs	0.000	0.416	0.584
C37 Malignant neoplasm of thymus	0.000	0.417	0.582
F22 Persistent delusional disorders	0.000	0.418	0.582
L29.3 Anogenital pruritus, unspecified	0.000	0.418	0.582
L29.1 Pruritus scroti	0.000	0.418	0.582
E10.8 With unspecified complications	0.000	0.418	0.582
E80 Disorders of porphyrin and bilirubin metabolism	0.000	0.418	0.582
D64.4 Congenital dyserythropoietic anaemia	0.000	0.419	0.581
D64.3 Other sideroblastic anaemias	0.000	0.419	0.581
D64.2 Secondary sideroblastic anaemia due to drugs and toxins	0.000	0.419	0.581
D64.1 Secondary sideroblastic anaemia due to disease	0.000	0.419	0.581
D64.0 Hereditary sideroblastic anaemia	0.000	0.419	0.581
C77.1 Intrathoracic lymph nodes	0.000	0.420	0.580
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.421	0.579
G82.4 Spastic tetraplegia	0.000	0.421	0.579
D86.0 Sarcoidosis of lung	0.000	0.422	0.578
I69 Sequelae of cerebrovascular disease	0.000	0.423	0.577
L30 Other dermatitis	0.000	0.423	0.577
G81.0 Flaccid hemiplegia	0.000	0.423	0.577
C18.8 Overlapping lesion of colon	0.000	0.423	0.577
C18.7 Sigmoid colon	0.000	0.424	0.576
L23 Allergic contact dermatitis	0.000	0.424	0.576
C79.2 Secondary malignant neoplasm of skin	0.000	0.425	0.575
G82.5 Tetraplegia, unspecified	0.000	0.425	0.575
F02.3 Dementia in Parkinson's disease	0.000	0.427	0.573
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.000	0.427	0.573
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.000	0.427	0.573
L57.5 Actinic granuloma	0.000	0.427	0.573
L57.3 Poikiloderma of Civatte	0.000	0.427	0.573
L57.2 Cutis rhomboidalis nuchae	0.000	0.427	0.573
L57.1 Actinic reticuloid	0.000	0.427	0.573
H80.9 Otosclerosis, unspecified	0.000	0.428	0.572
E88.9 Metabolic disorder, unspecified	0.000	0.429	0.571
E88.8 Other specified metabolic disorders	0.000	0.429	0.571
E88.3 Tumour lysis syndrome	0.000	0.429	0.571
E88.1 Lipodystrophy, not elsewhere classified	0.000	0.429	0.571
G70.9 Myoneural disorder, unspecified	0.000	0.429	0.570
G70.8 Other specified myoneural disorders	0.000	0.429	0.570
G70.2 Congenital and developmental myasthenia	0.000	0.429	0.570
G70.1 Toxic myoneural disorders	0.000	0.429	0.570
D57 Sickle-cell disorders	0.000	0.429	0.570
D56 Thalassaemia	0.000	0.429	0.570
D55 Anaemia due to enzyme disorders	0.000	0.429	0.570
M48 Other spondylopathies	0.568	0.432	0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.000	0.433	0.567
I60 Subarachnoid haemorrhage	0.000	0.436	0.564
F05.1 Delirium superimposed on dementia	0.000	0.436	0.564
D59.1 Other autoimmune haemolytic anaemias	0.000	0.436	0.564
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.437	0.563
B25-B34 Other viral diseases	0.000	0.437	0.563
F20.9 Schizophrenia, unspecified	0.000	0.437	0.563
E21.3 Hyperparathyroidism, unspecified	0.000	0.438	0.562
D68.5 Primary Thrombophilia	0.000	0.439	0.561
C43.4 Malignant melanoma of scalp and neck	0.000	0.441	0.559
F20.0 Paranoid schizophrenia	0.000	0.442	0.558
D86.1 Sarcoidosis of lymph nodes	0.000	0.443	0.557
E87.2 Acidosis	0.000	0.443	0.557
D83 Common variable immunodeficiency	0.000	0.444	0.555
D82 Immunodeficiency associated with other major defects	0.000	0.444	0.555
D81 Combined immunodeficiencies	0.000	0.444	0.555
F28 Other nonorganic psychotic disorders	0.000	0.446	0.554
F24 Induced delusional disorder	0.000	0.446	0.554
F21 Schizotypal disorder	0.000	0.446	0.554
D62 Acute posthaemorrhagic anaemia	0.000	0.447	0.553
I69.3 Sequelae of cerebral infarction	0.000	0.448	0.552
E74.9 Disorder of carbohydrate metabolism, unspecified	0.000	0.450	0.550
E74.8 Other specified disorders of carbohydrate metabolism	0.000	0.450	0.550
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.000	0.450	0.550
E74.2 Disorders of galactose metabolism	0.000	0.450	0.550
E74.1 Disorders of fructose metabolism	0.000	0.450	0.550
E74.0 Glycogen storage disease	0.000	0.450	0.550
D84 Other immunodeficiencies	0.000	0.451	0.549
D68.2 Hereditary deficiency of other clotting factors	0.000	0.451	0.549
E88.2 Lipomatosis, not elsewhere classified	0.000	0.452	0.548
F01.8 Other vascular dementia	0.000	0.452	0.548
F01.3 Mixed cortical and subcortical vascular dementia	0.000	0.452	0.548
F01.2 Subcortical vascular dementia	0.000	0.452	0.548
F01.1 Multi-infarct dementia	0.000	0.452	0.548
F01.0 Vascular dementia of acute onset	0.000	0.452	0.548
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.000	0.452	0.547
F00.1 Dementia in Alzheimer's disease with late onset	0.000	0.452	0.547
E23 Hypofunction and other disorders of pituitary gland	0.000	0.453	0.547
B34 Viral infection of unspecified site	0.000	0.453	0.547
C43.3 Malignant melanoma of other and unspecified parts of face	0.000	0.456	0.544
E65 Localised adiposity	0.000	0.456	0.544
L00-L08 Infections of the skin and subcutaneous tissue	0.000	0.456	0.544
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.000	0.457	0.543
C68 Malignant neoplasm of other and unspecified urinary organs	0.000	0.457	0.543
C44.1 Skin of eyelid, including canthus	0.000	0.458	0.542
C78.4 Secondary malignant neoplasm of small intestine	0.000	0.458	0.542
I95-I99 Other and unspecified disorders of the circulatory system	0.000	0.460	0.540
L13 Other bullous disorders	0.000	0.461	0.539
F23.9 Acute and transient psychotic disorder, unspecified	0.000	0.462	0.538
E05.8 Other thyrotoxicosis	0.000	0.462	0.537
G83 Other paralytic syndromes	0.000	0.462	0.537
F99-F99 Unspecified mental disorder	0.000	0.464	0.536
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.000	0.464	0.535
I63 Cerebral infarction	0.000	0.466	0.534
E20.8 Other hypoparathyroidism	0.000	0.466	0.533
E20.1 Pseudohypoparathyroidism	0.000	0.466	0.533
E20.0 Idiopathic hypoparathyroidism	0.000	0.466	0.533
C76.0 Head, face and neck	0.000	0.468	0.532
M47 Spondylosis	0.530	0.470	0.000
Chapter XXII Codes for special purposes	0.000	0.471	0.529
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.000	0.472	0.528
I70-I79 Diseases of arteries, arterioles and capillaries	0.000	0.472	0.528
L27.0 Generalised skin eruption due to drugs and medicaments	0.000	0.474	0.526
I95 Hypotension	0.000	0.475	0.525
C97 Malignant neoplasms of independent (primary) multiple sites	0.000	0.476	0.524
C73 Malignant neoplasm of thyroid gland	0.000	0.476	0.524
F25.9 Schizoaffective disorder, unspecified	0.000	0.477	0.523
C80 Malignant neoplasm without specification of site	0.000	0.477	0.523
L11 Other acantholytic disorders	0.000	0.478	0.522
F02.0 Dementia in Pick's disease	0.000	0.479	0.521
E53.8 Deficiency of other specified B group vitamins	0.000	0.480	0.520
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.000	0.480	0.519
C81 Hodgkin's disease	0.000	0.481	0.519
B34.9 Viral infection, unspecified	0.000	0.481	0.519
D41.4 Bladder	0.000	0.481	0.519
D68.0 Von Willebrand's disease	0.000	0.482	0.518
C75 Malignant neoplasm of other endocrine glands and related structures	0.000	0.483	0.517
C74 Malignant neoplasm of adrenal gland	0.000	0.483	0.517
D80 Immunodeficiency with predominantly antibody defects	0.000	0.483	0.517
L12 Pemphigoid	0.000	0.483	0.517
L10 Pemphigus	0.000	0.483	0.517
L14 Bullous disorders in diseases classified elsewhere	0.000	0.483	0.517
G31.1 Senile degeneration of brain, not elsewhere classified	0.000	0.484	0.515
E28 Ovarian dysfunction	0.000	0.485	0.515
I60.9 Subarachnoid haemorrhage, unspecified	0.000	0.486	0.514
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.486	0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.486	0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.486	0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.486	0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.486	0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.486	0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.486	0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.486	0.514
L21.8 Other seborrhoeic dermatitis	0.000	0.486	0.514
L21.1 Seborrhoeic infantile dermatitis	0.000	0.486	0.514
L21.0 Seborrhoea capitis	0.000	0.486	0.514
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.000	0.487	0.513
E70.8 Other disorders of aromatic amino-acid metabolism	0.000	0.487	0.513
E70.3 Albinism	0.000	0.487	0.513
E70.2 Disorders of tyrosine metabolism	0.000	0.487	0.513
E70.1 Other hyperphenylalaninaemias	0.000	0.487	0.513
E70.0 Classical phenylketonuria	0.000	0.487	0.513
E71.3 Disorders of fatty-acid metabolism	0.000	0.487	0.513
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.000	0.487	0.513
E71.1 Other disorders of branched-chain amino-acid metabolism	0.000	0.487	0.513
E71.0 Maple-syrup-urine disease	0.000	0.487	0.513
E72.9 Disorder of amino-acid metabolism, unspecified	0.000	0.487	0.513
E72.8 Other specified disorders of amino-acid metabolism	0.000	0.487	0.513
E72.5 Disorders of glycine metabolism	0.000	0.487	0.513
E72.4 Disorders of ornithine metabolism	0.000	0.487	0.513
E72.3 Disorders of lysine and hydroxylysine metabolism	0.000	0.487	0.513
E72.2 Disorders of urea cycle metabolism	0.000	0.487	0.513
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.000	0.487	0.513
E72.0 Disorders of amino-acid transport	0.000	0.487	0.513
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.000	0.487	0.513
E76.8 Other disorders of glucosaminoglycan metabolism	0.000	0.487	0.513
E76.3 Mucopolysaccharidosis, unspecified	0.000	0.487	0.513
E76.2 Other mucopolysaccharidoses	0.000	0.487	0.513
E76.1 Mucopolysaccharidosis, type II	0.000	0.487	0.513
E76.0 Mucopolysaccharidosis, type I	0.000	0.487	0.513
E77.9 Disorder of glycoprotein metabolism, unspecified	0.000	0.487	0.513
E77.8 Other disorders of glycoprotein metabolism	0.000	0.487	0.513
E77.1 Defects in glycoprotein degradation	0.000	0.487	0.513
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.000	0.487	0.513
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.000	0.487	0.513
E79.8 Other disorders of purine and pyrimidine metabolism	0.000	0.487	0.513
E79.1 Lesch-Nyhan syndrome	0.000	0.487	0.513
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.000	0.487	0.513
E84.9 Cystic fibrosis, unspecified	0.000	0.487	0.513
E84.8 Cystic fibrosis with other manifestations	0.000	0.487	0.513
E84.1 Cystic fibrosis with intestinal manifestations	0.000	0.487	0.513

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations